Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Characteristic times in sleep-waking electroencephalograms].

A Chornet-Lurbe1, J A Oteo, J Ros

  • 1Casa de Salud, Servicio de Neurofisiología Clínica, Valencia, España.

Revista De Neurologia
|October 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of treatment discontinuation among patients with microsatellite instability or mismatch repair-deficient metastatic colorectal cancer treated with immune checkpoint inhibitors.

ESMO open·2026
Same author

New prognostic and predictive scoring systems for colorectal cancer liver metastases.

ESMO open·2026
Same author

Retreatment with oxaliplatin-based regimens in refractory metastatic colorectal cancer: characterization of high-response patients.

ESMO gastrointestinal oncology·2026
Same author

Surrogate to predict overall survival in patients with <i>BRAF</i> V600E-mutant colorectal cancer treated with BRAF inhibitor combinations.

ESMO gastrointestinal oncology·2026
Same author

Safety and efficacy of encorafenib-cetuximab combination in <i>BRAF</i> <sup><i>V600E</i></sup> -mutated metastatic colorectal cancer: real-world evidence from the CONFIDENCE Spanish multicenter study.

ESMO real world data and digital oncology·2026
Same author

Efficacy and safety of atezolizumab plus bevacizumab in MSI-like metastatic colorectal cancer: a multicenter, single-arm, phase II, open-label clinical trial.

ESMO open·2025

This study introduces lacunarity analysis to characterize electroencephalogram (EEG) signals during sleep and wakefulness. The derived index effectively distinguishes awake states from specific sleep stages, offering a new tool for polysomnography interpretation.

Area of Science:

  • Neuroscience
  • Signal Processing
  • Biophysics

Context:

  • Electroencephalogram (EEG) signals reflect collective neuronal activity in the neocortex.
  • Brain function significantly influences EEG patterns.
  • Analyzing EEG texture can reveal insights into brain states.

Purpose:

  • To investigate if EEG signals contain discernible information about neuronal activity during different brain states.
  • To propose lacunarity analysis as a method for quantifying EEG signal texture.
  • To define a characteristic time index from lacunarity profiles for sleep/wake phases.

Summary:

  • Lacunarity patterns were computed for 30-second EEG epochs from polysomnographic recordings.
  • A characteristic time index was derived, yielding distinct values for wakefulness (0.12s), REM (0.65s), and sleep stages I (0.43s), II (0.73s), and III/IV (1.12s).

Related Experiment Videos

  • The awake state was clearly differentiated from sleep stages I and REM sleep.

    • Impact:

    • The lacunarity index shows potential as a complementary tool for interpreting polysomnographies.
    • This method may be applicable to diverse physiological and pathological EEG analysis scenarios.
    • Provides a novel quantitative approach to EEG analysis for sleep staging and brain state assessment.